Latest Capital Raising News

Austral Resources Australia Ltd has resumed trading on the ASX following news of a significant capital raising and a strategic investor commitment, signaling renewed confidence in the company’s future.

Tungsten Mining has secured $53 million to push its Mt Mulgine Project through critical feasibility stages while engaging international partners for processing and offtake. The company is positioning itself as a key player in the global tungsten market with strategic moves in the US and Europe.

TALi Digital Limited reported a 116% increase in half-year losses to $570,848 amid the integration of its recent acquisition, You Can Do It! Education. Revenue nearly doubled, reflecting early benefits from the expanded digital health and education platform.

Horizon Minerals has successfully raised A$175 million through a two-tranche institutional placement, complemented by a planned A$10 million share purchase plan, to fund the development of its Black Swan Processing Hub near Kalgoorlie.

WCM Global Growth Limited has raised approximately $85 million through a share placement and entitlement offer priced at $1.75 per share, aiming to strengthen its global growth investment strategy and enhance shareholder value.

Jameson Resources has marked significant progress in advancing its Crown Mountain steelmaking coal project, doubling its pre-tax NPV to US$942 million and moving closer to final environmental approvals and development permits expected by the end of 2026.

Elevra Lithium reported solid Q2 FY26 production and revenue results while progressing its North American Lithium brownfield expansion and forging strategic supply partnerships.

MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.

AuMEGA Metals has successfully upsized its institutional financing to C$30.1 million, anchored by Condire Investors who will hold nearly 20% of the company. The funds will accelerate exploration programs across its Newfoundland gold projects.

Bell Financial Group delivered a robust 17.1% rise in net profit after tax to $36 million for 2025, driven by strong growth in its Platforms division and a rebound in market activity. The company declared a fully franked final dividend of 6.5 cents per share, signalling confidence as it prepares to launch a new wealth management platform in 2026.

Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.

Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.